TGTX
TG Therapeutics Inc
NASDAQ: TGTX · HEALTHCARE · BIOTECHNOLOGY
$33.58
-2.89% today
Updated 2026-04-29
Market cap
$5.36B
P/E ratio
12.12
P/S ratio
8.70x
EPS (TTM)
$2.77
Dividend yield
—
52W range
$25 – $46
Volume
2.0M
TG Therapeutics Inc (TGTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+12.4%
Last 4 quarters
Revenue YoY growth
+78.0%
Most recent quarter
EPS YoY growth
-6.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.0%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-5.4%
2025-08-08
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $0.14 | -57.2% | $29.40 | $29.19 | -0.7% |
| 2025-11-03 | $2.43 | +1004.5% | $34.78 | $33.81 | -2.8% |
| 2025-08-08 | $0.17 | -10.5% | $27.89 | $26.39 | -5.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.33 | $0.14 | -57.2% | $192.57M | +78.0% |
| 2025-09-30 | $0.22 | $2.43 | +1004.5% | $161.71M | +92.8% |
| 2025-06-30 | $0.19 | $0.17 | -10.5% | $141.15M | +92.1% |
| 2025-03-31 | $0.17 | $0.03 | -82.8% | $120.86M | +90.4% |
| 2024-12-31 | $0.09 | $0.15 | +66.7% | $108.19M | +146.0% |
| 2024-09-30 | $0.03 | $0.02 | -33.3% | $83.88M | -49.4% |
| 2024-06-30 | $-0.05 | $0.04 | +180.0% | $73.47M | +357.0% |
| 2024-03-31 | $-0.04 | $-0.07 | -75.0% | $63.47M | +713.5% |
| 2023-12-31 | $-0.10 | $-0.10 | +0.0% | $43.97M | — |
| 2023-09-30 | $0.12 | $0.73 | +508.3% | $165.81M | — |
| 2023-06-30 | $-0.25 | $-0.34 | -36.0% | $16.07M | — |
| 2023-03-31 | $-0.37 | $-0.28 | +24.3% | $7.80M | — |
Frequently asked questions
Has TG Therapeutics Inc beaten earnings estimates?
TG Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +12.4% over the last 4 quarters.
How does TGTX stock react to earnings?
TGTX stock has moved an average of -3.0% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is TG Therapeutics Inc's revenue growth rate?
TG Therapeutics Inc reported year-over-year revenue growth of +78.0% in its most recent quarter, with EPS growing -6.7% year-over-year.